CAMBIA Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Cambia patents expire, and when can generic versions of Cambia launch?
Cambia is a drug marketed by Assertio and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.
This drug has thirty-four patent family members in twenty-three countries.
The generic ingredient in CAMBIA is diclofenac potassium. There are forty-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the diclofenac potassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cambia
A generic version of CAMBIA was approved as diclofenac potassium by TEVA on August 6th, 1998.
Summary for CAMBIA
International Patents: | 34 |
US Patents: | 4 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 54 |
Clinical Trials: | 3 |
Patent Applications: | 5,802 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CAMBIA |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CAMBIA |
What excipients (inactive ingredients) are in CAMBIA? | CAMBIA excipients list |
DailyMed Link: | CAMBIA at DailyMed |



Recent Clinical Trials for CAMBIA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Scripps Health | Phase 4 |
Depomed | Phase 4 |
Mayo Clinic | Phase 2/Phase 3 |
Pharmacology for CAMBIA
Drug Class | Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors |
Physiological Effect | Decreased Prostaglandin Production |
Anatomical Therapeutic Chemical (ATC) Classes for CAMBIA
Paragraph IV (Patent) Challenges for CAMBIA
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
CAMBIA | Oral Solution (Sachet) | diclofenac potassium | 50 mg | 022165 | 1 | 2011-01-24 |
US Patents and Regulatory Information for CAMBIA
CAMBIA is protected by four US patents.
Patents protecting CAMBIA
Diclofenac formulations and methods of use
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS
Diclofenac formulations and methods of use
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS
Diclofenac formulations and methods of use
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS
Diclofenac formulations and methods of use
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||
Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | Y | See Plans and Pricing | |
Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | Y | See Plans and Pricing | |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CAMBIA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | See Plans and Pricing | See Plans and Pricing |
Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CAMBIA
See the table below for patents covering CAMBIA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Mexico | 2007016072 | FORMULACIONES DE DICLOFENAC Y METODOS PARA USARLAS. (DICLOFENAC FORMULATIONS AND METHODS OF USE.) | See Plans and Pricing |
South Korea | 101352130 | See Plans and Pricing | |
New Zealand | 332655 | Pharmaceutical compositions containing diclofenac and alkali metal bicarbonates | See Plans and Pricing |
China | 101272768 | Diclofenac formulations and methods of use | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |